Fuller & Thaler Asset Management, Inc. Bristol Myers Squibb CO Transaction History

Fuller & Thaler Asset Management, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	SELL	$55.19 - $62.25 $596,052 - $672,300	-10,800 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$59.92 - $68.98 $383,488 - $441,472	-6,400 Reduced 37.21%	10,800 $683,000
Q3 2017 Nov 08, 2017	BUY	$55.23 - $63.74 $226,443 - $261,334	4,100 Added 31.3%	17,200 $1.1 Million
Q2 2017 Aug 14, 2017	BUY	N/A	13,100	13,100 $730,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Fuller & Thaler Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Fuller & Thaler Asset Management, Inc. with notifications on news.